CL2008001042A1 - Metodo para preparar compuestos derivados de imidazol; y un metodo para incrementar de mayor a menor la relacion de isomeros en una mezcla de dichos compuestos. - Google Patents

Metodo para preparar compuestos derivados de imidazol; y un metodo para incrementar de mayor a menor la relacion de isomeros en una mezcla de dichos compuestos.

Info

Publication number
CL2008001042A1
CL2008001042A1 CL200801042A CL2008001042A CL2008001042A1 CL 2008001042 A1 CL2008001042 A1 CL 2008001042A1 CL 200801042 A CL200801042 A CL 200801042A CL 2008001042 A CL2008001042 A CL 2008001042A CL 2008001042 A1 CL2008001042 A1 CL 2008001042A1
Authority
CL
Chile
Prior art keywords
compounds
imidazol
isomers
relationship
mixture
Prior art date
Application number
CL200801042A
Other languages
English (en)
Inventor
Wu Wenxue
Yan Jie
Zhang Haiming
Original Assignee
Lexicon Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39580118&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2008001042(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lexicon Pharmaceuticals Inc filed Critical Lexicon Pharmaceuticals Inc
Publication of CL2008001042A1 publication Critical patent/CL2008001042A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
CL200801042A 2007-04-12 2008-04-11 Metodo para preparar compuestos derivados de imidazol; y un metodo para incrementar de mayor a menor la relacion de isomeros en una mezcla de dichos compuestos. CL2008001042A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US92302907P 2007-04-12 2007-04-12

Publications (1)

Publication Number Publication Date
CL2008001042A1 true CL2008001042A1 (es) 2008-09-12

Family

ID=39580118

Family Applications (1)

Application Number Title Priority Date Filing Date
CL200801042A CL2008001042A1 (es) 2007-04-12 2008-04-11 Metodo para preparar compuestos derivados de imidazol; y un metodo para incrementar de mayor a menor la relacion de isomeros en una mezcla de dichos compuestos.

Country Status (23)

Country Link
US (2) US7812174B2 (es)
EP (1) EP2139864B1 (es)
JP (1) JP5398698B2 (es)
KR (1) KR20100015463A (es)
CN (1) CN101284817B (es)
AR (1) AR065980A1 (es)
AU (1) AU2008240251A1 (es)
BR (1) BRPI0810993A2 (es)
CA (1) CA2683445A1 (es)
CL (1) CL2008001042A1 (es)
CO (1) CO6231030A2 (es)
EA (1) EA017076B1 (es)
EC (1) ECSP099680A (es)
HK (1) HK1124842A1 (es)
IL (1) IL201075A0 (es)
MX (1) MX2009010903A (es)
NZ (1) NZ579691A (es)
PE (1) PE20090699A1 (es)
TW (1) TWI389891B (es)
UA (1) UA97664C2 (es)
UY (1) UY31013A1 (es)
WO (1) WO2008128041A2 (es)
ZA (2) ZA200906578B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY31013A1 (es) * 2007-04-12 2008-09-02 Lexicon Pharmaceuticals Inc Metodos para prepar compuestos basados en imidazol
TWI412362B (zh) * 2007-04-12 2013-10-21 Lexicon Pharmaceuticals Inc （ｅ）-１-（４-（（１ｒ，２ｓ，３ｒ）-１，２，３，４-四羥丁基）-１ｈ-咪唑-２-基）乙酮肟的固體形式
TW200920355A (en) * 2007-09-06 2009-05-16 Lexicon Pharmaceuticals Inc Compositions and methods for treating immunological and inflammatory diseases and disorders
TW201002698A (en) * 2008-06-18 2010-01-16 Lexicon Pharmaceuticals Inc Methods of preparing imidazole-based bicyclic compounds
AR074062A1 (es) * 2008-10-31 2010-12-22 Lexicon Pharmaceuticals Inc Agonistas del receptor s1p para el tratamiento de la malaria cerebral y forma farmaceutica
WO2011053546A1 (en) 2009-10-26 2011-05-05 Lexicon Pharmaceuticals, Inc. Methods of preparing 1-(4-((1r,2s,3r)-1,2,3,4-tetrahydroxybutyl)-1h-imidazol-2-yl)ethanone
CN102082785A (zh) * 2010-11-24 2011-06-01 蓝帽子(厦门)文化传播有限公司 线上线下游戏数据交互传输的认证加密装置及其认证方法
WO2013049272A2 (en) 2011-09-29 2013-04-04 Theraceutix, Llc Composition and method for treatment of symptoms associated with various skin conditions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4567194A (en) * 1983-03-10 1986-01-28 The Coca-Cola Company 2-Acylimidazole compounds, their synthesis and use as medicinal agents
US7649098B2 (en) * 2006-02-24 2010-01-19 Lexicon Pharmaceuticals, Inc. Imidazole-based compounds, compositions comprising them and methods of their use
UY31013A1 (es) 2007-04-12 2008-09-02 Lexicon Pharmaceuticals Inc Metodos para prepar compuestos basados en imidazol
TWI412362B (zh) * 2007-04-12 2013-10-21 Lexicon Pharmaceuticals Inc （ｅ）-１-（４-（（１ｒ，２ｓ，３ｒ）-１，２，３，４-四羥丁基）-１ｈ-咪唑-２-基）乙酮肟的固體形式

Also Published As

Publication number Publication date
US20080262241A1 (en) 2008-10-23
US7812174B2 (en) 2010-10-12
AR065980A1 (es) 2009-07-15
UY31013A1 (es) 2008-09-02
WO2008128041A3 (en) 2009-09-24
BRPI0810993A2 (pt) 2018-10-16
EA017076B1 (ru) 2012-09-28
EP2139864A2 (en) 2010-01-06
MX2009010903A (es) 2009-10-26
US8093280B2 (en) 2012-01-10
ZA201006678B (en) 2012-05-30
NZ579691A (en) 2011-12-22
CO6231030A2 (es) 2010-12-20
CN101284817B (zh) 2013-06-26
CN101284817A (zh) 2008-10-15
JP5398698B2 (ja) 2014-01-29
KR20100015463A (ko) 2010-02-12
JP2010523706A (ja) 2010-07-15
PE20090699A1 (es) 2009-07-08
UA97664C2 (uk) 2012-03-12
ECSP099680A (es) 2009-12-28
ZA200906578B (en) 2010-11-24
EA200970939A1 (ru) 2010-04-30
EP2139864B1 (en) 2015-12-02
TWI389891B (zh) 2013-03-21
TW200902502A (en) 2009-01-16
AU2008240251A1 (en) 2008-10-23
IL201075A0 (en) 2010-05-17
WO2008128041A2 (en) 2008-10-23
CA2683445A1 (en) 2008-10-23
US20110071303A1 (en) 2011-03-24
HK1124842A1 (en) 2009-07-24

Similar Documents

Publication Publication Date Title
CL2007001040A1 (es) Proceso para la preparacion de antagonista de la sustancia p derivado de acil-amino-alquilen-amida.
CL2008000322A1 (es) Proceso para la preparacion de un compuesto derivado de 2-tiazol-2-il-quinolina; compuestos intermediarios; y proceso de preparacion de dichos compuestos intermediarios.
BR112012000968A2 (pt) composto, composição e método para inibir uma fosfatidil inositol-3 cinase.
CL2008001042A1 (es) Metodo para preparar compuestos derivados de imidazol; y un metodo para incrementar de mayor a menor la relacion de isomeros en una mezcla de dichos compuestos.
IT1391483B1 (it) Procedimento per la preparazione di un materiale composito autoriparantesi
DK2086944T3 (da) Fremgangsmåde til fremstilling af difluormethylpyrazolylcarboxylater
BRPI0914918A2 (pt) forma de dosagem farmacêutica, e, método para preparar uma forma de dosagem sólida.
FI20055616A0 (fi) Menetelmä valmisteen rakenteen muokkaamiseen
BRPI0905910A2 (pt) Método para fabricar materiais mesoporosos, materiais assim produzidos e uso de materiais mesoporosos.
BRPI0909691A2 (pt) Composto, método para preparar um composto, e, composição farmacêutica
CR10705A (es) Anticuerpos para linfotoxina-alfa
BRPI0813858A2 (pt) Método para produzir peptídeo
BRPI0815550A2 (pt) Método para estabilizar fenilefrina
BRPI0812999A2 (pt) Método para preparar um composto
BRPI0912539A2 (pt) composto, composição farmacêutica , método para tratar uma doença, e, uso do composto.
EP2135901A4 (en) CONNECTION FOR PHOTORESIST, PHOTORESIST SOLUTION AND USE OF THIS PROCESS
BRPI0815796A2 (pt) Compósito elastomérico e método para produzi-lo.
BRPI0918736A2 (pt) método para produzir leite modificado.
BRPI0911897A2 (pt) Processo para a preparação de compostos, e, composto
FI20065363A0 (fi) Erotusmenetelmä
BRPI1009816A2 (pt) "método para preparar um composto."
BRPI0921248A2 (pt) silme de superfície para estrutura compósitas.
BRPI0814011A2 (pt) método para preparação de biobutanol
BRPI0719529A2 (pt) Método para produzir uma preparação sólida, e, preparação sólida.
BRPI0916847A2 (pt) preparação sólida, e, métodos para estabilizar um composto e para melhorar a propriedade de dissolução de um composto.